At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 683 enrolled
Drug / intervention
placebo +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK0974 Co-administered With Ibuprofen or Acetaminophen in Patients With Migraine With or Without Aura
In Brief
A Phase 2 clinical trial evaluating placebo, ibuprofen, and 2 other interventions for Migraine. Completed, enrolled 683 participants.
Detailed Summary
This study will test the safety and how effective telcagepant is when taken with ibuprofen or acetaminophen in participants with migraine with or without aura. The primary study hypothesis is that at least one drug combination is superior to telecagepant alone in the treatment of acute migraines.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2008
Enrollment StartDec 2008
Primary CompletionAug 2009
TodayJul 2026
First PostedSep 25, 2008
Enrollment StartDec 3, 2008
Primary CompletionAug 24, 2009
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.8 years ago
Interventions
placebodrug
ibuprofendrug
acetominophendrug
telcagepantdrug